Health – “Risks of thrombosis are very low,” say U.S. health officials
U.S. health officials gave the green light for a resumption Johnson & Johnson vaccinated with serum In the United States, it was suspended on April 13 after rare thrombosis events. “The use of Johnson’s Govt-19 vaccine is expected to resume in the United States,” the Centers for Disease Control and Prevention (CDC) and the FDA, a US pharmaceutical company, said in a statement. Advantages of the vaccine Risks in people 18 years of age and older.
The breakdown in the use of the vaccine, developed by a U.S. laboratory, was decided to investigate several cases of women who developed severe cases of blood clots in combination with low platelets after injection. “The FDA and CDC are confident that this vaccine will be safe and effective in preventing Govt-19,” both companies said. “For now, the available data suggest that the risk of” thrombosis “is very low, but the FDA and CDC will remain vigilant and continue to investigate this risk,” the text states.
Three out of 8 million deaths
Managing health workers (…) Read more in 20 minutes
You may also be interested in this content:
“Certified food fanatic. Extreme internet guru. Gamer. Evil beeraholic. Zombie ninja. Problem solver. Unapologetic alcohol lover.”